Your browser doesn't support javascript.
loading
Long-Term Outcomes of Laparoscopic Nephroureterectomy with Transurethral Circumferential Excision of the Ureteral Orifice for Urothelial Carcinoma.
Pai, Aakash; Hussain, Muddassar; Hindley, Richard; Emara, Amr; Barber, Neil.
Afiliação
  • Pai A; 1 Department of Urology, Frimley Park Health NHS Foundation Trust , Frimley, United Kingdom .
  • Hussain M; 1 Department of Urology, Frimley Park Health NHS Foundation Trust , Frimley, United Kingdom .
  • Hindley R; 1 Department of Urology, Frimley Park Health NHS Foundation Trust , Frimley, United Kingdom .
  • Emara A; 2 Department of Urology, Hampshire Hospitals NHS Foundation Trust , Basingstoke, United Kingdom .
  • Barber N; 1 Department of Urology, Frimley Park Health NHS Foundation Trust , Frimley, United Kingdom .
J Endourol ; 31(7): 651-654, 2017 07.
Article em En | MEDLINE | ID: mdl-28385045
INTRODUCTION: When performing open or laparoscopic nephroureterectomy (LNU), the optimal way to excise the distal ureter remains controversial. There are concerns that primary endoscopic detachment of the intramural ureter is associated with adverse outcomes. Existing studies have limited number of patients and inadequate oncologic follow-up. We provide our institutions experience of this technique. MATERIALS AND METHODS: Data were collected prospectively on 59 patients (37 men) who underwent LNU for a 10-year period at a single center using a standardized technique: initial endoscopic circumferential release of the distal ureter and bladder cuff followed by retroperitoneal en bloc LNU. RESULTS: Patients had a mean age of 67 years and Charlson score of 2. One case was converted to open surgery. Mean operative time was 194 minutes with estimated blood loss of 125 mL. Three patients (5%) required a blood transfusion. Mean in-patient stay was 3 days. Forty-six patients had urothelial carcinoma. Seventy-one percent of patients had high-grade disease (n = 33) and 21% had distal ureteral disease (n = 10). One patient required open excision of recurrence at the site of the excised ureteral orifice and remains disease free 5 years later. Five-year cancer-specific survival was 100% for patients with stages pTa (n = 7) and pT1 (n = 14), 93% for stage pT2 (n = 7) disease, and 49% for patients with stage pT3 (n = 18) disease. CONCLUSIONS: Transurethral resection of the ureteral orifice during LNU achieves acceptable long-term oncologic outcomes while minimizing perioperative morbidity and in-patient stay. This represents the largest single-center study of this technique to date.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ureter / Carcinoma de Células de Transição / Neoplasias Urológicas / Laparoscopia / Nefroureterectomia / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ureter / Carcinoma de Células de Transição / Neoplasias Urológicas / Laparoscopia / Nefroureterectomia / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article